Skip to main content
OpenTrials

Clinical trial condition

Human Metapneumovirus and Human Parainfluenza Infection

Explore clinical trials studying Human Metapneumovirus and Human Parainfluenza Infection. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Human Metapneumovirus and Human Parainfluenza Infection trial results

Completed

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

NCT04144348

Conditions
Human Metapneumovirus and Human Parainfluenza Infection, Infections, Mononegavirales Infections, +3 more
Locations
  • Central Research Associates Inc Birmingham, Alabama, United States
  • Meridian Clinical Research Washington D.C., District of Columbia, United States
  • Clinical Research Prime Idaho Falls, Idaho, United States
  • Heartland Research Associates LLC El Dorado, Kansas, United States
View all 19 locations
View Trial Details

Related conditions